The glucocorticoid sparing efficacy of Phytopica™ in the management of canine atopic dermatitis

Veterinary Dermatology

Volumn 21, Issue 1, 2010, Pages 97-105

  Schmidt, Vanessa ^a   McEwan, Neil ^a   Volk, Andrea ^b   Helps, John ^c   Morrell, Kevin ^d   Nuttall, Tim ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c Intervet/Schering Plough Animal Health   (United Kingdom)

^d Phytopharm plc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 77949526080     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00858.x     Document Type: Article

References (33)

1. Scott DW, Miller WH, Griffin C. Skin immune system and allergic skin disease. Small Animal Dermatology 2001, 543-666. Muller, Kirk, In, ed, Philadelphia, W.B. Saunders
2. Olivry T, Mueller RS. Evidence based veterinary dermatology: a systemic review of the pharmacotherapy of atopic dermatitis. Veterinary Dermatology 2003, 14:121-46.
3. Nuttall TJ, Mueller RS, Bensignor E. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo controlled trial. Veterinary Dermatology 2009, 20:191-8.
4. Ferguson EA, Littlewood JD, Carlotti DN. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study. Veterinary Dermatology 2006, 17:236-43.
5. Nagle TM, Torres SM, Horne KL. A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis. Veterinary Dermatology 2001, 12:265-74.
6. Horvath-Ungerboeck C, Thoday KL, Shaw DJ. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomised, double-blinded, placebo-controlled, cross-over study. Veterinary Dermatology 2009, 20:233-42.
7. Mueller RS, Fettman MJ, Richardson K. The effect of omega-3 fatty acid supplementation on cutaneous and plasma fatty acid concentrations in dogs with atopic dermatitis. Veterinary Dermatology 2004, 15. abstract
8. Saevik B, Bergvall K, Holm BR. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology 2004, 15:137-45.
9. Bensignor E, Morgan DM, Nuttall T. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study. Veterinary Dermatology 2008, 19:156-62.
10. Glos K, Linek M, Loewenstein C. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis. Veterinary Dermatology 2008, 19:280-7.
11. Olivry T, Marsella R, Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? Veterinary Immunology and Immunopathology 2001, 81:347-62.
12. DeBoer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis (XXI): antihistamine pharmacotherapy. Veterinary Immunology and Immunopathology 2001, 81:323-9.
13. Bond R, Lloyd DH. Combined treatment with concentrated essential fatty acids and prednisolone in the management of canine atopy. Veterinary Record 1994, 134:30-2.
14. Prélaud P, Guaguère E, Alhaidari Z. Reevaluation of diagnostic criteria of canine atopic dermatitis. Revue de Medecine Veterinaire 1998, 149:1057-64.
15. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001, 81:271-6.
16. Olivry T, Marsella R, Iwasaki T. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Veterinary Dermatology 2007, 18:78-86.
17. Olivry T, Mueller R, Nuttall T. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Veterinary Dermatology 2008, 19:115-9.
18. Plant JD. Repeatability and reproducibility of numerical rating scales and visual analogue scales for canine pruritus severity scoring. Veterinary Dermatology 2007, 18:294-300.
19. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Veterinary Dermatology 2007, 18:301-8.
20. Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy. Veterinary Immunology and Immunopathology 2001, 81:317-22.
21. Huang HP, Yang HL, Liang SL. Iatrogenic hyperadrenocorticism in 28 Dogs. Journal of the American Animal Hospital Association 1999, 35:200-7.
22. Budzinski JW, Foster BC, Vandenhoek S. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000, 7:273-82.
23. Kim HK, Park Y, Kim HN. Antimicrobial mechanism of beta-glycyrrhetinic acid isolated from licorice, Glycyrrhiza glabra. Biotechnology Letters 2002, 24:1899-902.
24. Kirby AJ, Schmidt RJ. The antioxidant activity of Chinese herbs for eczema and of placebo herbs. Journal of Ethnopharmacology 1997, 56:103-8.
25. Lee SE, Hwang HJ, Ha JS. Screening of medicinal plant extracts for antioxidant activity. Life Sciences 2003, 73:167-79.
26. Watanabe M, Hayakawa S, Isemura M. Identification of licocoumarone as an apoptosis-inducing component in licorice. Biological and Pharmaceutical Bulletin 2002, 25:1388-90.
27. Yamashiki M, Nishimura A, Suzuki H. Effects of the Japanese herbal medicine " Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997, 25:1390-7.
28. Kim H, Lee E, Lee S. Effect of Rehmannia glutinosa on immediate type allergic reaction. International Journal of Immunopharmacology 1998, 20:231-40.
29. Kim HM, An CS, Jung KY. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacological Research 1999, 40:171-6.
30. Kang JH, Park YH, Choi SW. Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells. Experimental and Molecular Medicine 2003, 35:467-74.
31. Kim HJ, Chang EJ, Cho SH. Antioxidative activity of resveratrol and its derivatives isolated from seeds of Paeonia lactiflora. Bioscience Biotechnology and Biochemistry 2002, 66:1990-3.
32. Lee SJ, Lee IS, Mar W. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D- glucose in murine macrophage cells. Archives of Pharmacal Research 2003, 26:832-9.
33. Prieto JM, Recio MC, Giner RM. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. Journal of Pharmacy and Pharmacology 2003, 55:1275-82.